Area of research
Pulmonary and Respiratory Medicine · Gastroenterology
Research interest
Research interests include Gastric Cancer Management and Outcomes, Celiac Disease Research and Management, Chronic Obstructive Pulmonary Disease (COPD) Research, and Gastrointestinal Tumor Research and Treatment.
Additional benefit of standardized computed tomography-based lymph node assessment utilizing Node-RADS in esophageal adenocarcinoma
Krankheitsbilder - Dünn- und Dickdarm
Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group.
S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma–final results of the randomized AIO MATEO phase II trial
S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma-final results of the randomized AIO MATEO phase II trial.
Individual hematotoxicity prediction of further chemotherapy cycles by dynamic mathematical models in patients with gastrointestinal tumors.
Response prediction in patients with gastric and esophagogastric adenocarcinoma under neoadjuvant chemotherapy using targeted gene expression analysis and next-generation sequencing in pre-therapeutic biopsies.
Treatment of right hepatic artery stump bleeding after pylorus-preserving pancreaticoduodenectomy by covered stent endoprosthesis placement.
Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—a randomized phase II trial of the AIO pancreatic cancer group
PuraStat in gastrointestinal bleeding: results of a prospective multicentre observational pilot study.
Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome.
The combination of clinical parameters and immunophenotyping of intraepithelial lymphocytes allows to assess disease severity in refractory celiac disease
Perioperative or adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Updated final results of the randomized phase II AIO-NEONAX trial.
S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus
Inhibition of MACC1-Induced Metastasis in Esophageal and Gastric Adenocarcinomas
S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus.
The combination of clinical parameters and immunophenotyping of intraepithelial lymphocytes allows to assess disease severity in refractory celiac disease.
Inhibition of MACC1-Induced Metastasis in Esophageal and Gastric Adenocarcinomas.
Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas
Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas.
Impact of Postoperative Chemotherapy in Patients with Gastric/Gastroesophageal Adenocarcinoma Treated with Perioperative Chemotherapy.
Hereditary Diffuse Gastric Cancer-Update Based on the Current Consort Recommendations.
[Long-term response in advanced pancreatic adenocarcinoma - a case report and literature review].
Frequency of Positive Familial Criteria in Patients with Adenocarcinoma of the Esophageal-Gastric Junction and Stomach: First Prospective Data in a Caucasian Cohort.
PuraStat in gastrointestinal bleeding: results of a prospective multicentre observational pilot study
Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome
Results from the German registry for refractory celiac disease.
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas.
Reduction of Postoperative Wound Infections by Antiseptica (RECIPE)?: A Randomized Controlled Trial.